Biomedical Engineering Reference
In-Depth Information
76. Hussey, RE,
. (1988). A soluble CD4 protein selectively inhibits HIV
replication and syncytium formation.
et al
Nature
,
331
. pp. 78-81.
77. Clayton, R,
. (2007). Binding kinetics, uptake and intracellular
accumulation of F105, an anti-gp120 human IgG1kappa monoclonal
antibody, in HIV-1 infected cells.
et al
. pp. 17-23.
78. Zhou, J, Li, H, Li, S, Zaia, J, and Rossi, JJ (2008). Novel dual inhibitory
function aptamer-siRNA delivery system for HIV-1 therapy.
J Virol Methods
,
139
Mol Ther
,
. pp. 1481-1489.
79. Neff, CP,
16
. (2011). An aptamer-siRNA chimera suppresses HIV-1
viral loads and protects from helper CD4(+) T cell decline in humanized
mice.
et al
. pp. 66ra66.
80. Sattentau, QJ, and Moore, JP (1993). The role of CD4 in HIV binding and
entry.
Sci Transl Med
,
3
. pp. 59-66.
81. Dalgleish, AG, Beverley, PC, Clapham, PR, Crawford, DH, Greaves, MF,
and Weiss, RA (1984). The CD4 (T4) antigen is an essential component
of the receptor for the AIDS retrovirus.
Philos Trans R Soc Lond B Biol Sci
,
342
Nature
,
312
. pp. 763-767.
82. Wheeler, LA,
. (2011). Inhibition of HIV transmission in human
cervicovaginal explants and humanized mice using CD4 aptamer-
siRNA chimeras.
et al
. pp. 2401-2412.
83. Guo, P (2010). The emerging field of RNA nanotechnology.
J Clin Invest
,
121
Nat
. pp. 833-842.
84. Shu, Y, Cinier, M, Shu, D, and Guo, P (2011). Assembly of multifunctional
phi29 pRNA nanoparticles for specific delivery of siRNA and other
therapeutics to targeted cells.
Nanotechnol
,
5
. pp. 204-214.
85. Guo, P (2005). RNA nanotechnology: engineering, assembly and
applications in detection, gene delivery and therapy.
Methods
,
54
J Nanosci
. pp. 1964-1982.
86. Farokhzad, OC, Jon, S, Khademhosseini, A, Tran, TN, Lavan, DA, and
Langer, R (2004). Nanoparticle-aptamer bioconjugates: a new approach
for targeting prostate cancer cells.
Nanotechnol
,
5
Cancer Res
,
64
. pp. 7668-7672.
87. Farokhzad, OC,
. (2006). Targeted nanoparticle-aptamer
bioconjugates for cancer chemotherapy
et
al
in vivo
.
Proc Natl Acad Sci
. pp. 6315-6320.
88. Dhar, S, Gu, FX, Langer, R, Farokhzad, OC, and Lippard, SJ (2008).
Targeted delivery of cisplatin to prostate cancer cells by aptamer
functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
USA
,
103
Proc Natl
Acad Sci USA
,
105
. pp. 17356-17361.
89. Gu, F,
. (2008). Precise engineering of targeted nanoparticles by
using self-assembled biointegrated block copolymers.
et al
Proc Natl Acad
Sci USA
,
105
. pp. 2586-2591.
Search WWH ::
Custom Search